Oligonucleotide Therapy

Oligonucleotide therapies are novel treatments that use small pieces of DNA or RNA, known as oligonucleotides, to treat a wide range of diseases and conditions. These oligonucleotides can be designed to target specific disease-causing genes or gene sequences.

Oligonucleotide drugs are introduced into the body to treat genetic disorders, cancers and certain infectious diseases. There are several different approaches to oligonucleotide therapy, including antisense oligonucleotides, RNA interference, and CRISPR-based therapies. Each approach has its own applications, and careful consideration is needed for selection of analytical technologies.

Our Danaher Life Sciences companies offer a wide range of solutions, technologies and services to support the development and manufacturing of synthetic oligonucleotides.  If you are interested in learning more, please consult with our workflow solutions architects.

Oligonucleotide Therapy Solutions

To learn more about oligonucleotide therapy solutions from the Life Sciences companies of Danaher Corporation visit: